Lorence H. Kim
CIK: 0001643746
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Sep 8, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Indirect371 shares at avg. $212.27$79K - Sep 8, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Indirect3.8K shares at avg. $211.36$812K - Sep 8, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Indirect2.9K shares at avg. $209.56$598K - Sep 8, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Indirect4.7K shares at avg. $210.50$996K - Sep 8, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Indirect706 shares at avg. $206.60$146K - Sep 8, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Indirect999 shares at avg. $207.33$207K - Sep 8, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Indirect3.6K shares at avg. $208.55$748K - Aug 31, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Indirect2.1K shares at avg. $205.19$437K - Aug 31, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Indirect300 shares at avg. $200.56$60K - Aug 31, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Indirect6.6K shares at avg. $201.47$1.3M - Aug 31, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Indirect12.9K shares at avg. $202.48$2.6M - Aug 31, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Indirect26.2K shares at avg. $203.55$5.3M - Aug 31, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Indirect7.3K shares at avg. $204.35$1.5M - Aug 31, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Indirect625 shares at avg. $206.15$129K - Jun 18, 2026RVMD
Revolution Medicines, Inc.
Award(A)Direct1.2K shares- - Mar 5, 2026COR
Cencora, Inc.
Award(A)Direct557 shares at avg. $359.28$200K - Jun 26, 2025RVMD
Revolution Medicines, Inc.
Award(A)Direct3.1K shares- - Mar 6, 2025COR
Cencora, Inc.
Award(A)Direct789 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 8, 2026 |  RVMD Revolution Medicines, Inc. | Sale(S) | 371 | $212.27 | $78,752 | Indirect |
| Sep 8, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 3,844 | $211.36 | $812,463 | Indirect |
| Sep 8, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 2,853 | $209.56 | $597,875 | Indirect |
| Sep 8, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 4,730 | $210.50 | $995,678 | Indirect |
| Sep 8, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 706 | $206.60 | $145,863 | Indirect |
| Sep 8, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 999 | $207.33 | $207,125 | Indirect |
| Sep 8, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 3,587 | $208.55 | $748,081 | Indirect |
| Aug 31, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 2,128 | $205.19 | $436,640 | Indirect |
| Aug 31, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 300 | $200.56 | $60,168 | Indirect |
| Aug 31, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 6,597 | $201.47 | $1,329,117 | Indirect |
| Aug 31, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 12,919 | $202.48 | $2,615,864 | Indirect |
| Aug 31, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 26,160 | $203.55 | $5,324,824 | Indirect |
| Aug 31, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 7,271 | $204.35 | $1,485,830 | Indirect |
| Aug 31, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 625 | $206.15 | $128,846 | Indirect |
| Jun 18, 2026 | RVMD Revolution Medicines, Inc. | Award(A) | 1,191 | - | $0 | Direct |
| Mar 5, 2026 |  COR Cencora, Inc. | Award(A) | 557 | $359.28 | $200,119 | Direct |
| Jun 26, 2025 | RVMD Revolution Medicines, Inc. | Award(A) | 3,142 | - | - | Direct |
| Mar 6, 2025 | COR Cencora, Inc. | Award(A) | 789 | - | - | Direct |
1-18 of 18 transactions
About Kim Lorence H.
Kim Lorence H. (SEC CIK 0001643746) files insider reports with the SEC as Director of Revolution Medicines, Inc. (RVMD) and Director of Cencora, Inc. (COR).
Signal8 holds 6 ownership filings by Kim Lorence H., all Form 4s, filed between Mar 10, 2025 and Sep 10, 2026. Those filings report 18 transactions, from Mar 6, 2025 to Sep 8, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Kim Lorence H.'s filings is in REDWOOD CITY, CA.
Recent filings by Kim Lorence H.
- Sep 8, 2026: Open-market sales of RVMD shares (7 lines, Form 4, code S).
- Aug 31, 2026: Open-market sales of RVMD shares (7 lines, Form 4, code S).
- Jun 18, 2026: Grant or award of RVMD shares (Form 4, code A).
- Mar 5, 2026: Grant or award of COR shares (Form 4, code A).
- Jun 26, 2025: Grant or award of RVMD shares (Form 4, code A).
Other insiders filing for Revolution Medicines, Inc. (RVMD)
- Mancini Anthony
- Sandler Alan B., Chief Development Officer
- Cislini Jeff, SVP & General Counsel
- ANDERSON ELIZABETH M, Director
- Kelsey Stephen Michael
- Horn Margaret A, Chief Operating Officer